September 14, 2009 โ The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
Feature | Dave Fornell
Gregg W. Stone, M.D., offered a preview Sept. 10 of some of the key, late-breaking clinical trials and trends in ...
September 10, 2009
September 10, 2009 โ Regado Biosciences said this week it enrolled the first patient in a phase 2b, randomized ...
September 10, 2009
September 8, 2009 โ Actelion Pharmaceuticals U.S. Inc. recently announced the first commercial sales of a new 20 ...
September 08, 2009
September 3, 2009 โ Important new findings in patients with angina participating in the BEAUTIFUL study show that ...
September 03, 2009
September 3, 2009 โ The OASIS study group presented initial results of the CURRENT-OASIS 7 clinical trial Sunday ...
September 03, 2009September 2, 2009 โ A new analysis from the JUPITER study showed CRESTOR (rosuvastatin calcium) 20 mg reduced the ...
September 02, 2009
September 1, 2009 โ Cordis Corp. said first patient has been enrolled in the CYPRESS study, which will assess ...
September 01, 2009
September 1, 2009 โ Sanofi-aventis said Sunday the investigational anti-Xa intravenous anti-coagulant otamixaban ...
September 01, 2009
September 1, 2009 โ AstraZeneca last week announced results from the phase III head to head trial, PLATO (A Study ...
September 01, 2009
August 13, 2009 โ Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed ...
August 13, 2009August 13, 2009 โ The pharmaceutical and healthcare research firm Decision Resources found Merck/Schering-Plough ...
August 13, 2009August 10, 2009 โ Health Care Service Corp. (HCSC), which operates the Blue Cross and Blue Shield plans in ...
August 10, 2009August 6, 2009 โ Palatin Technologies Inc. said this week it received a notice of allowance from the U.S. Patent ...
August 06, 2009
August 6, 2009 โ Merck & Co. Schering-Plough Corp. and the companies' cholesterol joint venture, Merck/Schering ...
August 06, 2009ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now